CytoVac A/S

Cytovac is a growing Danish biotech company, focusing on development of a cancer treatment that uses the body’s own immune system.

Promising results gained by the dedicated research team over a number of years, have brought about the development of the ALECSAT therapy. ALECSAT is a therapy based on injection of activated cells from the immune system.